L’Oreal shares traded higher in Paris Monday after the luxury group bought three skincare lines from Valeant Pharmaceuticals for $1.3 billion in a bid to expand its skincare portfolio. The Paris-based beauty and hair care product manufacturer entered an agreement to buy the skincare brands CeraVe, Acne Free and Ambi from Valeant.